The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Scott John K Jr. since 2019.
This trader's CIK number is 1753763.
At the time of last reporting, Scott John K Jr. was the Director of Navidea Biopharmaceuticals, Inc.. (stock ticker symbol NAVB).
Also see all insider trading activities at Navidea Biopharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | NAVB | 3,260 | $0 | 0 | $0 | 0 | $0 |
| 2020 | NAVB | 2,378,529 | $2,042,499 | 0 | $0 | 0 | $0 |
| 2019 | NAVB | 4,912,698 | $3,549,999 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-04-10 | NAVB | Buy | 3,260 | .00 | 0 |
| 2020-08-30 | NAVB | Buy | 5,000 | 5.00 | 25,000 |
| 2020-02-13 | NAVB | Buy | 2,373,529 | .85 | 2,017,499 |
| 2019-12-06 | NAVB | Buy | 555,555 | .90 | 499,999 |
| 2019-06-18 | NAVB | Buy | 4,000,000 | .75 | 3,000,000 |
| 2019-03-22 | NAVB | Buy | 357,143 | .14 | 50,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Scott John K Jr. (Director of Navidea Biopharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.